Literature DB >> 2413372

Role of adenosine 3',5'-cyclic monophosphate in adrenoceptor-mediated control of 3H-noradrenaline secretion in guinea-pig ileum myenteric nerve terminals.

P Alberts, V R Ogren, A I Sellström.   

Abstract

Secretion of 3H-noradrenaline was evoked by electrical field stimulation (1 Hz, 300 shocks) in guinea-pig ileum myenteric plexus. The role of cyclic nucleotides in the presynaptic receptor-mediated control of 3H-noradrenaline secretion was studied. The secretion of 3H-noradrenaline was maximally enhanced to the same extent, viz. 300-400% of control, by two analogues of cyclic AMP (8-Br cyclic AMP and dibutyryl cyclic AMP), by an adenylate cyclase activator (forskolin) and by three structurally different inhibitors of phosphodiesterase (3-isobutyl-1-methylxanthine, SQ 20,006 and Ro 20-1724), but not altered by two analogues of cyclic GMP (8-Br cyclic GMP and dibutyryl cyclic GMP). Added separately an alpha 2-adrenoceptor antagonist (yohimbine) and a beta-adrenoceptor agonist (isoprenaline) enhanced the 3H-noradrenaline secretion. Yohimbine, but not isoprenaline, increased additively the 'maximal enhancement' of the 3H-noradrenaline secretion caused by 3-isobutyl-1-methylxanthine. These results suggest that neuronal cyclic AMP may be involved in beta- but not in alpha-adrenoceptor-mediated control of 3H-noradrenaline secretion in guinea-pig ileum myenteric nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413372     DOI: 10.1007/bf00499903

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  42 in total

Review 1.  Cyclic nucleotides and nervous system function.

Authors:  J A Nathanson
Journal:  Physiol Rev       Date:  1977-04       Impact factor: 37.312

2.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

3.  Analogues of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone as potent inhibitors of rat erythrocyte adenosine cyclic 3',5'-phosphate phosphodiesterase.

Authors:  H Sheppard; G Wiggan
Journal:  Mol Pharmacol       Date:  1971-01       Impact factor: 4.436

Review 4.  Mechanisms of facilitation and muscarinic or alpha-adrenergic inhibition of acetylcholine and noradrenaline secretion from peripheral nerves.

Authors:  P Alberts
Journal:  Acta Physiol Scand Suppl       Date:  1982

5.  Influence of temperature on stimulus-secretion coupling in the sympathetic nerves and on neuromuscular transmission, in guinea-pig vas deferens.

Authors:  L Stjärne; P Alberts
Journal:  Acta Physiol Scand       Date:  1985-10

6.  Differential labelling of intraneuronal noradrenaline stores with different concentrations of (-)-3H-noradrenaline.

Authors:  J Hughes
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

7.  Xanthine derivatives as adenosine receptor antagonists.

Authors:  B B Fredholm; C G Persson
Journal:  Eur J Pharmacol       Date:  1982-07-30       Impact factor: 4.432

8.  Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.

Authors:  I Cavero; N Shepperson; F Lefèvre-Borg; S Z Langer
Journal:  Circ Res       Date:  1983-02       Impact factor: 17.367

Review 9.  Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Authors:  K B Seamon; J W Daly
Journal:  J Cyclic Nucleotide Res       Date:  1981

10.  Site(s) and ionic basis of alpha-autoinhibition and facilitation of "3H'noradrenaline secretion in guinea-pig vas deferens.

Authors:  P Alberts; T Bartfai; L Stjärne
Journal:  J Physiol       Date:  1981-03       Impact factor: 5.182

View more
  10 in total

1.  Effects of cyclic GMP and analogues on neurogenic transmission in the rat tail artery.

Authors:  S Ouedraogo; M Tschöpl; J C Stoclet; B Bucher
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

2.  Protein kinase C activation increases noradrenaline release from the rat hippocampus and modifies the inhibitory effect of alpha 2-adrenoceptor and adenosine A1-receptor agonists.

Authors:  B B Fredholm; E Lindgren
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

3.  Effect of phorbol esters and polymyxin B on modulation of noradrenaline release in mouse atria.

Authors:  I F Musgrave; H Majewski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

4.  Role of cyclic AMP in the release of noradrenaline from isolated rat atria. Effect of pretreatment with clenbuterol.

Authors:  M G Kazanietz; M A Enero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

5.  Involvement of cyclic nucleotides in prejunctional modulation of noradrenaline release in mouse atria.

Authors:  H Johnston; H Majewski; I F Musgrave
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

6.  Facilitation of noradrenaline release from sympathetic nerves through activation of ACTH receptors, beta-adrenoceptors and angiotensin II receptors.

Authors:  M Costa; H Majewski
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

7.  Interaction of forskolin with the effect of atropine on [3H]acetylcholine secretion in guinea-pig ileum myenteric plexus.

Authors:  P Alberts; V R Ogren
Journal:  J Physiol       Date:  1988-01       Impact factor: 5.182

8.  Pertussis toxin does not attenuate alpha 2-adrenoceptor mediated inhibition of noradrenaline release in mouse atria.

Authors:  I Musgrave; P Marley; H Majewski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

9.  Subtype classification of the presynaptic alpha-adrenoceptors which regulate [3H]-noradrenaline secretion in guinea-pig isolated urethra.

Authors:  P Alberts
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

10.  Role of cyclic AMP in the prejunctional alpha 2-adrenoceptor modulation of noradrenaline release from the rat tail artery.

Authors:  B Bucher; L Pain; J C Stoclet; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.